Thermo Fisher closes $13.6B Life Tech acquisition

Thermo Fisher ($TMO) has closed its mammoth $13.6 billion buyout of Life Technologies, barely a few days after U.S. antitrust regulators signed off on the deal. The acquisition breaks down to $76.13 in cash per fully diluted common share, plus the assumption of $1.5 billion in net debt. The Waltham, MA, laboratory sealed the deal after obtaining regulatory sign-offs from European, Chinese and then U.S. regulators, and had to agree to sell off certain divisions before the Life Tech buyout could be completed. Item

Suggested Articles

J&J’s Ethicon unit received an FDA clearance for its Vistaseal applicators that spray a biologic sealant from Grifols to help stem surgical bleeding.

Bio-Techne’s urine test has received a breakthrough device designation from the FDA for ruling out unnecessary tissue biopsies.

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.